GLAXOSMITHKLINE CONSUMER HEALTHCARE LTD. - Q3 results on Feb 13, 2017

GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 13, 2017, inter alia, to consider and take on record the Unaudited Financial Results of the Company for the quarter ended December 31, 2016 (Q3) with Limited Review by Statutory Auditors.